Merck is the latest pharmaceutical company to rush an experimental drug to market to treat the SARS-CoV-2 virus.
Merck announced Friday that it has developed an experimental oral drug that will reduce hospitalizations and deaths by 50% in people recently infected with Covid.
The company will ask the Food & Drug Administration (FDA) for emergency authorization to distribute the capsules.
The drug -- which some compare to Ivermectin and Tamiflu -- is intended as a treatment for people with Covid symptoms.
Former FDA Director Dr. Scott Gottlieb told CNBC that the trial results are clearly "profoundly" positive.
supersizer / E+ / Getty Images
Merck allegedly tested the drug on 700 unvaccinated people diagnosed with Covid-19 in a global study.
The volunteers were all considered "high risk" due to factors like age, and pre-existing medical conditions.
Merck's study found that 7% of volunteers in the control group that received the drug were hospitalized, and none of them died. While 14% were hospitalized and eight people died in the placebo group.
Dr. Gottlieb calls the test results a "a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic."
Dr. Gottlieb also noted that the team that developed the drug "also invented the first successful antibody against ebola so this is a very good drug-development team."
The drug is intended to be taken in addition to the mRNA vaccines.
Lawmakers in Georgia, Kentucky, and Texas have proposed legislation to ban doctors from prescribing puberty blockers and other hormone drugs for children.
Georgia State Rep. Ginny Ehrhart is drafting a bill that would block medical providers from facilitating a medical "transition" for minors by prescribing puberty blockers and cross-sex hormones.
The lawmakers acted out of a sense of concern for children after a Texas mother brainwashed her 3-year-old son to believe he was a girl.
The child, now 7, attended school as a boy for the first time in his young life this week. His mother, a pediatrician, convinced the youngster that he was a girl because he played with a girl's toy in a McDonald's happy meal when he was 3.
The boy's father asked a judge to grant him full custody of the boy, but a Texas jury awarded primary custody to the mother and allowed her to continue transitioning the boy into a girl.
In response to the overwhelming public backlash, the presiding judge overturned the jury's decision.
"We're talking about children that can't get a tattoo or smoke a cigar or a cigarette in the state of Georgia, but can be castrated and get sterilized," Ehrhart told the Atlanta Journal-Constitution.
In 2018, Ehrhart defeated Democrat Jen Slipakoff, who is raising her son as "transgender" because at 2 years old he showed an interest in pink pajamas and cupcakes.
People who "transition" their minor children to the opposite sex tend to be white women who suffer from Munchausen by proxy syndrome.
Munchausen by proxy syndrome is a mental condition in which a parent or caregiver fakes or causes illness in children for attention from healthcare workers and the news media.
Rapper Wiz Khalifa, 30, is using his substantial platform to warn vulnerable youth about the dangers of popping pills and sipping Lean or Sizzurp.
Read more »
Rapper Iggy Azalea is blaming an accidental mixup of prescription drugs for her Snapchat rant against her record label on Thursday night.
The 26-year-old Aussie rapper claims she accidentally mixed up her prescription meds and experienced a strong reaction that drove her to lash out at her record label for delaying her unanticipated new album.
Read more »
Cuban Harry, a close associate of drug-addled rapper Li'l Wayne, was busted on charges of masterminding dozens of pharmacy burglaries in South Miami.
Read more »
Martin Shkrell is not so bad after all. The 32-year-old hedge fund manager sparked a public outcry when he raised price of an anti-parasitic drug from $13.50 a pill to $750 a pill.
Shkreli purchased the rights to sell Daraprim, a drug that treats potentially deadly parasitic infections in the elderly, infants, and AIDS patients.
The 5,000% price increase drew sharp criticism from lawmakers as well as infectious disease specialists.
Read more »